Drug-eluting scaffold superior to angioplasty for infrapopliteal artery disease

1. In this randomized controlled trial, for patients with chronic limb-threatening ischemia (CLTI) due to infrapopliteal artery disease (IAD), a drug-eluting resorbable scaffold was superior to angioplasty in reducing the risk of vascular events.  2. There was no significant difference in the adverse events between the drug-eluting resorbable scaffold and angioplasty groups.  Evidence Rating Level: […]

The post Drug-eluting scaffold superior to angioplasty for infrapopliteal artery disease first appeared on 2 Minute Medicine.